STALLERGENES-GREER
26.10.2021 14:45:14 CEST | Business Wire | Press release
Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced that the company has entered into an exclusive partnership with Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, for the development of the first of its kind connected device and companion mobile app for patients undergoing Stallergenes Greer’s AIT treatments with sublingual solutions.
“This exclusive partnership with Aptar Pharma demonstrates the intensification of Stallergenes Greer’s investments in innovation to provide a large range of precise personalised allergen immunotherapy options adapted to the individual needs and lifestyle of patients. Stallergenes Greer is well advanced on its digital transformation journey and will continue to develop its e-health offering for the benefit of all stakeholders,” stated Dominique Pezziardi, General manager France, Belgium and Luxembourg, Global Head of Pricing and Market Access.
Non-adherence to an AIT schedule and premature discontinuation of treatment remain a challenge in AIT management. This innovative, easy-to-use connected device will contribute to improving dose compliance and adherence, thus optimising treatment outcomes.
The development work is being undertaken by Aptar Pharma’s Digital Health group, which has capabilities and expertise in device and software development. The product will leverage Aptar Pharma’s Cohero platform, which will be tailored specifically for this use.
“We are pleased to combine Aptar Pharma’s Digital Health ecosystem with Stallergenes Greer’s knowledge and leading position in AIT to further improve the treatment journey of patients who suffer from allergies,” said Sai Shankar, Vice President, Global Digital Healthcare Systems, Aptar Pharma.
The newly developed connected device should be available in France in 2022 and will be progressively rolled-out in Stallergenes Greer’s markets.
This innovation further illustrates Stallergenes Greer’s commitment to build on precision medicine and personalised healthcare which cater to the needs of both patients and the medical community.
ABOUT STALLERGENES GREER LTD
Headquartered in London (UK), Stallergenes Greer Ltd is a global healthcare company specialising in the diagnosis and treatment of allergies through the development and commercialisation of allergy immunotherapy products and services. Stallergenes Greer Ltd is the parent company of Greer Laboratories, Inc. (whose registered office is in the United States) and Stallergenes SAS (whose registered office is in France). For more information, visit www.stallergenesgreer.com
ABOUT APTAR PHARMA
Aptar Pharma is part of Aptar Group Inc., a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home, food and beverage. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211026005769/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Textron Aviation Opens New Melbourne Service Facility at Essendon Fields Airport, Expanding Support for Cessna, Beechcraft and Hawker Customers in APAC5.5.2026 17:00:00 CEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, today announced its new service facility at Essendon Fields Airport in Melbourne is now open for customers, expanding factory-direct support for Cessna, Beechcraft and Hawker customers across Australia and the Asia-Pacific region. The purpose-built facility strengthens Textron Aviation’s global service network and reflects the company’s long-term commitment to expanding capacity and enhancing customer support throughout aircraft ownership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260505135152/en/ Textron Aviation opens new Melbourne service facility at Essendon Fields airport, expanding support for Cessna, Beechcraft and Hawker customers in APAC “We’ve supported customers in Australia for decades, and we continue to invest where our customers tell us they need more capacity and faster access to factory direct expertise,” said Brian Rohloff, senior vice presiden
Doha Debates Podcast Examines the Global Questions Shaping Society5.5.2026 16:37:00 CEST | Press release
Weekly Tuesday releases from January 6 through June 2 extend conversations from Doha Debates’ flagship debates and global town halls Qatar Foundation’s Doha Debates continues the rollout of its weekly Doha Debates Podcast episodes, airing every Tuesday through June 2. Since launching on January 6, the season has brought leading global thinkers into direct conversation on the defining questions of our time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260505299576/en/ Doha Debates podcast examines the global questions shaping society. Weekly Tuesday releases from January 6 through June 2 extend conversations from Doha Debates’ flagship debates and global town halls. (Photo: AETOSWire) The Doha Debates Podcast extends themes first explored in Doha Debates’ flagship debates and town halls, offering deeper, sustained exchanges that connect disciplines, regions and worldviews through open, truth-seeking dialogue. The latest epi
INRIX Unveils Global Standard for Traffic Signal Intelligence5.5.2026 16:34:00 CEST | Press release
Latest updates to INRIX Signal Analytics deliver expanded scale, confidence, and performance insight for cities worldwide INRIX, a global leader in transportation analytics and mobility intelligence, today announced a series of major updates to its award-winning Signal AnalyticsTM platform. These updates deliver unprecedented scale, statistical confidence, and flexibility by combining INRIX’s proven signal performance methodology with newly integrated traffic data, creating the most comprehensive, data-richsignal analytics solution to date. “INRIX Signal Analytics saves hours of monitoring every week by identifying where problems exist and enabling data-driven decisions that improve efficiency and safety at our intersections. It has been a valuable tool for optimizing our signal operations,” said Aaron M Torres, Traffic Operations Manager, Osceola County, Florida. With these updates, transportation agencies can now monitor, diagnose, and improve signalized intersections without install
Convatec’s Advanced Wound Care Innovation Leads the Industry at European Wound Management Association (EWMA) 20265.5.2026 16:11:00 CEST | Press release
Convatec will showcase new clinical and real‑world evidence across next‑generation foam technology, nitric oxide‑generating dressings, and Wound HygieneConvatec-sponsored scientific symposia to spotlight patient-centred innovation supported by robust in-vitro and clinical data enabling HCPs to deliver better outcomesConvatec to unveil Aquacel™ ConvaFiber™ in its European debut ahead of scale-up later this year Convatec, a leading medical products and technology company focused on chronic condition management, takes to the stage to showcase the breadth, depth and momentum behind its Advanced Wound Care innovation pipeline at the European Wound Management Association (EWMA) 2026 conference in Bremen, Germany, from 6–8 May 2026. Convatec’s industry-leading Advanced Wound Care innovation is supported by compelling new data from randomised controlled trials (RCTs) and real-world studies, with 13 abstracts accepted for publication and presentation at EWMA evaluating outcomes in hard-to-heal
Laserfiche Recognized as a Leader in 2026 Gartner® Magic Quadrant™ for Document Management5.5.2026 16:00:00 CEST | Press release
Laserfiche named a Leader for the second consecutive time based on its Completeness of Vision and Ability to Execute Laserfiche — the leading SaaS provider of intelligent content management — has been positioned as a Leader in the 2026 Magic Quadrant for Document Management. Laserfiche believes this recognition underscores the company’s commitment to empowering organizations to transform complex, operational business processes through AI-powered content management. “It’s incredible to see Laserfiche recognized during the same week as our annual Empower conference, where we announced our latest agentic AI capabilities,” said Thomas Phelps, senior vice president of corporate strategy and chief information officer at Laserfiche. “We believe being positioned as a Leader — and receiving the highest overall rating among 16 vendors in Gartner Peer Insights, with a 4.7 out of 5.0 based on over 1,300 reviews as of April 30, 2026 — reflects our relentless focus on product innovation and deliveri
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom